Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit has affirmed the US Patent and Trademark Office’s patent term adjustment of a Mayo Foundation-owned patent. 18 September 2019
Big Pharma
This week at the AIPPI World Congress 2019, counsel discussed how supplementary protection certificates and patent term extension regulations differ across jurisdictions. 17 September 2019
Big Pharma
The Court of Justice of the European Union last week issued its decision in a case concerning whether a ‘launch at risk’ bars compensation for a wrongfully issued preliminary injunction. 17 September 2019
Americas
A couple who worked at Ohio-based research institute Nationwide Children’s Hospital have been charged with stealing trade secrets and then using the information to market products through their Chinese company. 17 September 2019
Big Pharma
A district court has upped Vectura’s award of $89.7 million in damages by $10m, after a jury trial earlier this year found that GlaxoSmithKline has willfully infringed one of its patents. 16 September 2019
Big Pharma
The Trump administration has pledged to crack down on the sale of unauthorised vape products, amid growing public health concerns over the safety of e-cigarettes. 12 September 2019
Genetics
The University of Columbia has hit Illumina with a patent infringement suit relating to next-generation DNA sequencing, just days after the pharmaceutical company had one of the university’s patents invalidated at the US Patent and Trial Appeal Board. 12 September 2019
Europe
The world's ”largest genetics project” to tackle deadly diseases was launched yesterday, September 11, supported by funding from the UK government, charities and four pharmaceutical companies. 12 September 2019
article
European Federation of Pharmaceutical Industries and Associations has welcomed a mission letter from the EU president-elect, which promises to invest in new health sector technologies, promote healthy lifestyles and forge better cooperation within the EU. 11 September 2019
Americas
Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation. 10 September 2019